Amneal Says Fed. Circ. Redo In Drug Patent Row Unnecessary
Amneal Pharmaceuticals urged the Federal Circuit on Wednesday to deny Merck & Co.'s request for reconsideration, or full rehearing, of a panel's decision affirming that a generic nasal spray Amneal sells...To view the full article, register now.
Already a subscriber? Click here to view full article